Clinical trial reportThe British journal of dermatologyPublished
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The British journal of dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Psoriasis; Antibodies, Monoclonal; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Antibodies, Monoclonal, Humanized; Adalimumab
- PubMed ID
- 37022762
- Added to directory
- Source checked